Newsfeeds - Spark Newswire

1 minute read

Stifel Initiates Coverage On Rapid Micro Biosystems with Buy Rating, Announces Price Target of $28

Today, 9:20 AM

Stifel analyst Stephen Gengaro initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Buy rating and announces Price Target of $28.

RPID

1 minute read

JP Morgan Initiates Coverage On Rapid Micro Biosystems with Overweight Rating, Announces Price Target of $30

By Benzinga Newsdesk

Today, 9:20 AM

JP Morgan analyst Tycho Peterson initiates coverage on Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight rating and announces Price Target of $30.

RPID

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 9:20 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

3 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 9:20 AM

Wednesday's morning session saw 27 companies set new 52-week lows.

ASZ

2 minute read

M&A
News

Longitude Capital Highlights Closing Of Its Inaugural Longitude Prime Fund, Fund’s First Investment In Rapid Micro Biosystems

By Benzinga Newsdesk

Today, 9:20 AM

- Longitude Prime Fund makes first investment in IPO of Rapid Micro Biosystems, the industry leading automated quality-control platform for pharmaceutical manufacturing - MENLO PARK, Calif., GREENWICH, Conn., and

RPID